Evolution of the Average Target: DaVita Inc.

Evolution of the Target Price: DaVita Inc.

Changes in Analyst Recommendations: DaVita Inc.

1a7d441c10a693261b814.lGXw_eNzwje9281G8PWDkxB34FgPwgj1MAyOrQdKWYQ.2QS7h4Iep0H6k48Pu6PO9EMi2DNLpUTHCHi6lFUJO9XmB8SPux-DVM-W9Q~a52460290c8faa37ec0b47476ea3468b
08-07 Truist Adjusts Price Target on DaVita to $215 From $250, Maintains Hold Rating MT
08-05 Barclays Adjusts Price Target on DaVita to $224 From $218 MT
08-05 BofA Adjusts Price Target on DaVita to $170 From $145 MT
08-05 Deutsche Bank Adjusts DaVita Price Target to $265 From $220, Maintains Buy Rating MT
07-14 Truist Raises Price Target on DaVita to $250 From $205, Keeps Hold Rating MT
07-10 DaVita Can Return to Long-Term Volume Growth of 2% by 2029, UBS Says MT
07-10 UBS Adjusts Price Target on DaVita to $270 From $235 MT
07-08 Barclays Adjusts Price Target on DaVita to $218 From $194 MT
05-11 TD Cowen Adjusts Price Target on DaVita to $201 From $144 MT
05-11 Analyst recommendations: Biomarin Pharmaceuticals, Walt Disney, Apollo Global Management, Datadog, Roku… Zonebourse
05-08 Truist Securities Adjusts DaVita Price Target to $205 From $158, Maintains Hold Rating MT
05-07 UBS Adjusts Price Target on DaVita to $235 From $190, Maintains Buy Rating MT
05-07 Barclays Adjusts Price Target on DaVita to $194 From $158 MT
05-06 DaVita Shares Rise After Deutsche Bank Upgrade MT
05-06 Deutsche Bank Upgrades DaVita to Buy From Hold, Raises Price Target to $220 From $126 MT
02-05 Truist Raises Price Target on DaVita to $158 From $128, Keeps Hold Rating MT
02-05 Analyst recommendations: Corteva, Snap, Alphabet, Eli Lilly, PayPal, Qualcomm… Zonebourse
02-04 TD Cowen Adjusts DaVita Price Target to $144 From $133, Maintains Hold Rating MT
02-04 UBS Adjusts Price Target on DaVita to $190 From $186, Maintains Buy Rating MT
02-03 Barclays Adjusts Price Target on DaVita to $158 From $143 MT
01-05 Truist Adjusts Price Target on DaVita to $128 From $140, Maintains Hold Rating MT
11-03 TD Cowen Adjusts Price Target on DaVita to $133 From $154 MT
25-10-30 Barclays Adjusts Price Target on DaVita to $143 From $149 MT
25-10-30 Deutsche Bank Adjusts Price Target on DaVita to $126 From $137 MT
25-10-08 Barclays Adjusts Price Target on DaVita to $149 From $160 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+25.66%
+24.79%
+5.19%
+0.6%
+12.5%
+0.61%
+39.46%
+6.63%
+9.41%
+17.3%
Average +14.22%
Weighted average by Cap. +14.47%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
173.82USD
Average target price
218.43USD
Spread / Average Target
+25.66%
High Price Target
270.00USD
Spread / Highest target
+55.33%
Low Price Target
165.00USD
Spread / Lowest Target
-5.07%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Truist Securities
Barclays
Deutsche Bank Securities
BofA Securities
UBS
TD Cowen
Bernstein
Cowen
RBC Capital Markets
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
173.82USD
Average target price
218.43USD
Spread / Average Target
+25.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DVA Stock
  4. Consensus DaVita Inc.